Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > We are down 40%+ Since January

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on May 01, 2024 1:35pm

35 Views

Post# 36017765

RE:RE:We are down 40%+ Since January

So a SP of $5 is a pre rev. spit of only $1.25, what an outstanding job they’re NOT doing….I propose a negative 70% bonus to start paying us (the actual owners) back.

Trogarzon wrote: This stock should be 5$ at least with only an once of effort and talent from the management. It's a disgrace and they compensate themselves with 70%+ of their target bonuses. They make me sick.

<< Previous

Bullboard Posts

Next >>

Silver One discovers new silver veins and copper on Arizona project